Research contract
Genomatrix Software GmbH of Munich was awarded a €1.3 million BioChance
research contract from the German Federal Ministry of Education and
Research to extend the reach of its RNAi-mediated regulatory networks
technology. Genomatrix’s skills in gene regulation will be complemented
by academic collaborators from LMU Munich and DKFZ Heidelberg.
“Regulatory RNAs represent a very important, yet underestimated component of gene regulation,” said Thomas Werner, CEO and CSO of Genomatrix. The work carried out as a result of the grant will enhance the company’s microarray analysis systems.
www.genomatrix.de
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
